Search Results - Ke-Rui Wang

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

    Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS) by Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Xiang Li, Si-Qi Zhang, Ke-Rui Wang, Ke-Rui Wang, Shi-Nan Wu, Shi-Nan Wu, Meng-Yuan Wang, Meng-Yuan Wang, Cui-Ting Chen, Cui-Ting Chen, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong, Nuo Dong

    Published 2025-06-01

    ObjectiveThis study aimed to evaluate the risk of adverse events associated with chloroquine (CQ) and hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE), using data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).MethodsDisproportionality a...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: